FDAnews Device Daily Bulletin

ROCHE DIAGNOSTICS AMPLICHIP CYP450 TEST NOW AVAILABLE FROM LABCORP

Nov. 29, 2005
A A

Laboratory Corporation of America Holdings (LabCorp) recently announced the availability of Roche Diagnostics' Cytochrome AmpliChip P450 2D6/2C19 Genotyping and Phenotyping Assay as an enhancement to LabCorp's growing pharmacogenetics test menu. Cleared by the U.S. Food and Drug Administration for diagnostic use, the assay utilizes DNA microarray technology to provide a rapid method of identifying multiple genetic variants in two cytochrome P450 (CYP450) genes, CYP2D6 and CYP2C19.
Yahoo News